Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium – 1997–2006–2016. Part 2
Open Access
- 21 January 2016
- journal article
- editorial
- Published by SAGE Publications in Acta Radiologica
- Vol. 57 (6) , 643-648
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Current status of nephrogenic systemic fibrosisClinical Radiology, 2014
- Acute Adverse Reactions to Gadolinium-Based Contrast Media2014
- NSF after Gadovist exposure: a case report and hypothesis of NSF developmentNephrology Dialysis Transplantation, 2009
- Risk of Nephrogenic Systemic Fibrosis: Evaluation of Gadolinium Chelate Contrast Agents at Four American UniversitiesRadiology, 2008
- Extracellular Gd-CA: Differences in prevalence of NSFEuropean Journal of Radiology, 2008
- Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reportingEuropean Journal of Radiology, 2008
- High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast AgentInvestigative Radiology, 2008
- Cutaneous changes of nephrogenic systemic fibrosis: Predictor of early mortality and association with gadolinium exposureArthritis & Rheumatism, 2007
- ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosisEuropean Radiology, 2007
- Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agentsCancer Imaging, 2007